Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611)☆
- Citation:
- J Geriatr Oncol vol 9 (4) 321-28
- Year:
- 2018
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 7
- Parents:
- 2574
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Older Adult
- Sec. Committees:
- Leukemia Lymphoma
- Pharmas:
- Grants:
- UG1CA189823, U10CA180790, U10CA180833, U10CA180836, U10CA180838, U10CA180850, U10CA180857
- Corr. Author:
- Authors:
- Michael Tallarico Jared C. Foster Drew Seisler Jacqueline M. Lafky Arti Hurria Aminah Jatoi Harvey J. Cohen Hyman B. Muss Nancy Bartlett Bruce D. Cheson Sin-Ho Jung John P. Leonard John C. Byrd Chadi Nabhan
- Networks:
- CAPITAL, CARLE, LAPS-IL057, LAPS-MN026, LAPS-MO011, LAPS-NC007, LAPS-NC010, NY018, OH070
- Study
- Alliance-A151611
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- N/A
- Keywords: